| 000 | 01719 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517031820.0 | ||
| 264 | 0 | _c20160223 | |
| 008 | 201602s 0 0 eng d | ||
| 022 | _a2041-4889 | ||
| 024 | 7 |
_a10.1038/cddis.2015.77 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCheng, H-W | |
| 245 | 0 | 0 |
_aIdentification of thioridazine, an antipsychotic drug, as an antiglioblastoma and anticancer stem cell agent using public gene expression data. _h[electronic resource] |
| 260 |
_bCell death & disease _cMay 2015 |
||
| 300 |
_ae1753 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntipsychotic Agents _xpharmacology |
| 650 | 0 | 4 |
_aAutophagy _xdrug effects |
| 650 | 0 | 4 |
_aBrain Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aDrug Screening Assays, Antitumor _xmethods |
| 650 | 0 | 4 | _aGene Expression Profiling |
| 650 | 0 | 4 |
_aGlioblastoma _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice, Inbred NOD |
| 650 | 0 | 4 | _aMice, SCID |
| 650 | 0 | 4 |
_aNeoplastic Stem Cells _xdrug effects |
| 650 | 0 | 4 | _aRandom Allocation |
| 650 | 0 | 4 |
_aThioridazine _xpharmacology |
| 650 | 0 | 4 | _aXenograft Model Antitumor Assays |
| 700 | 1 | _aLiang, Y-H | |
| 700 | 1 | _aKuo, Y-L | |
| 700 | 1 | _aChuu, C-P | |
| 700 | 1 | _aLin, C-Y | |
| 700 | 1 | _aLee, M-H | |
| 700 | 1 | _aWu, A T H | |
| 700 | 1 | _aYeh, C-T | |
| 700 | 1 | _aChen, E I-T | |
| 700 | 1 | _aWhang-Peng, J | |
| 700 | 1 | _aSu, C-L | |
| 700 | 1 | _aHuang, C-Y F | |
| 773 | 0 |
_tCell death & disease _gvol. 6 _gp. e1753 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/cddis.2015.77 _zAvailable from publisher's website |
| 999 |
_c24877608 _d24877608 |
||